Navigation Links
Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
Date:2/26/2008

JAMA, February 27, 2008 - Vol. 299. No. 8: 'Venous Thromboembolism and

Mortality Associated with Recombinant Erythropoietin and Darbepoetin

Administration for the Treatment of Cancer-Associated Anemia'

BRIDGEWATER, N.J., Feb. 26 /PRNewswire/ -- Ortho Biotech believes that the conclusions of a study published in the February 27, 2008 issue of the Journal of the American Medical Association (JAMA) by Bennett, et al, do not provide an accurate reflection of the safety profile of erythropoiesis-stimulating agents (ESAs) when used for the treatment of chemotherapy-induced anemia (CIA) in patients with cancer.

The company reaffirms that, when used according to product labeling, ESAs remain safe and effective, and are the only proven treatment alternative to blood transfusions for patients with CIA.

Ortho Biotech also provides comment on the following important topics.

Meta-Analyses

Ortho Biotech acknowledges that all meta-analyses have limitations. However, the JAMA authors recognize that a significant limitation of this analysis is that it does not analyze patient-level data from all available controlled studies with ESAs.

In a separate effort, Ortho Biotech, along with the other ESA manufacturers, has provided individual patient-level data to the independent Cochrane Collaboration to support a combined analysis of all available controlled studies with ESAs in oncology patients. This project will be the largest combined analysis of ESA safety data ever undertaken. It will create a database of more than 15,000 patients treated in various clinical studies, which should inform the benefit:risk profile of ESAs by identifying patient subgroups that would benefit from further study.

VTEs

Vascular thrombotic events (VTEs) are a well-recognized risk of ESA treatment and are prominently reflected in the labeling for all ESAs. It is important to understand that VTEs are common in cancer patients. VTEs may
'/>"/>

SOURCE Ortho Biotech
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
2. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
3. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
4. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
5. Bone-growing nanomaterial could improve orthopaedic implants
6. Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
7. Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
8. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings
9. Progentix Orthobiology B.V. Closes Series A Financing Round
10. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
11. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COPENHAGEN, Dec. 2 The world,...oIsoprene technology, a breakthrough alternative t... the manufacture of synthetic rubber with renewabl..., this week. One tire will be on display at a loun...International Airport throughout December 21, whil...
(Date:12/2/2009)..., LIBREVILLE, Gabon, December 2 /PRNewswire...ca: Everyone,s Problem and Heritage" , Co...ty, 2-3 June 2010 the,Gabonese Republic is hosting... on the issue of safeguarding biological resources...ernment and state leaders, ministers,scientific e...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNe...ty study evaluating the preclinical (animal study)...ch combines technology from Weill,Cornell Medical ...ntial to,treat inherited anemias such as Cooley,s ...ies of technologies to expand, ex vivo,population...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-Asia...e "Company") (NYSE: SCR ), a leading pharmaceuti...acturing, and marketing of branded,generic and pro... that 105 of,its drugs have been included in China...h was issued by China,s Ministry of Human Resource...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...ate Growth of Pain Franchise, FRAZER, Pa., Aug. 2...t has signed an agreement to acquire the North,Ame...oride extended-release,capsules) from ECR Pharmace...ngths of AMRIX (15 mg and 30 mg) were approved in ...tion (FDA) for short-term use as an adjunct to,res...
...nBio Pharma,Inc. (OTC Bulletin Board: APNB) an eme...development of novel drugs and diagnostics for ani...o list its common stock on the,NASDAQ Capital Mark... anticipates its shares of common stock will begin... of trading on Tuesday, August 28,2007, under the ...
...ssful GAMMAGARD LIQUID and GAMMAGARD S/D, [Immune ...neered by Baxter, DEERFIELD, Ill., Aug. 22 Baxte... that it will launch GARDian, an innovative,progra... relying on,GAMMAGARD LIQUID and GAMMAGARD S/D [Im...oducts like GAMMAGARD LIQUID and GAMMAGARD S/D are...
Other Biology Technology:Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 2Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 3Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant 4AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 2AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 3AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 2Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 3Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 5Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 6Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 7Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 8Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 9
(Date:12/2/2009)...anut butter, and other foods have done more than r...y. They also are quietly fueling a boom in the mar...ood safety regulations. That,s the topic of the tw...al & Engineering News , (C&EN) ACS, weekly newsmag...nd Senior Correspondent Marc Reisch point out that...
(Date:12/2/2009)...f undergraduate students from Stevens Institute of...oster contest hosted by the International Society ...ual contest highlights the research conducted by t...nual Meeting in San Diego, Calif. , The winning ... Ligament Tensioning Device," was presented by Aar...
(Date:12/2/2009)...e a higher IQ and are more likely to go on to univ...he Sahlgrenska Academy and Sahlgrenska University ...the prestigious Proceedings of the National Acade...illion Swedish men doing military service who were...alysed the results of both physical and IQ tests w...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2Extra Hour to Prepare 3A APHA Reminds You to Check Emergency Stockpile Kits When Setting Your Clocks on Nov 1 59844 1Extra Hour to Prepare 3A APHA Reminds You to Check Emergency Stockpile Kits When Setting Your Clocks on Nov 1 59844 2CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 1CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 2CARE President to Speak at Inaugural Event of New Leadership Series on Women and Global Development 59840 3Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call 59836 1Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call 59836 2
... A major step in the development of the vertebrate...into a brain, spinal cord and muscles - turns out ...ee signals to make sure it happens properly. , Th...velopmental Cell by researchers at the University ...ar-old observation that revolutionized the way bio...
... UCLA biochemists have determined the three-dimens...he enzyme that helps maintain telomeres ?small pie...protective caps -- allowing DNA ends to be copied ...he first major piece of telomerase for which the s...most cancers, and this work ultimately may lead to...
... Agilent Technologies Inc. (NYSE: A) today announc...p design, probe sequence and annotation informatio...information is expected to improve cross-laborator...mparison. , "Full release of the probe sequences i...t to take," said Catherine Ball, president of the ...
Other Biology News:Scientists discover that three overlapping signals in embryo help get the backbone right 2Scientists discover that three overlapping signals in embryo help get the backbone right 3Scientists discover that three overlapping signals in embryo help get the backbone right 4Scientists discover that three overlapping signals in embryo help get the backbone right 5Biochemists report discovery of structure of major piece of telomerase; implications for cancer 2Biochemists report discovery of structure of major piece of telomerase; implications for cancer 3Virus-host interactions at sea effect global photosynthesis 2
...nd PowerPac basic power supply are used for submer...s in agarose gels. The Mini-Sub cell GT cell inclu... a 7 x 7 cm UV-transparent gel tray with fluoresce...height combs (8- and 15-well). The PowerPac basic ...
...owerPac basic power supply are used for submerged ... agarose gels. This Model 96 cell includes a buffe...fluorescent ruler, and a gel caster. The PowerPac ...s output of 10-300 V, 4-400 mA, and 75 W. Power co...
...PowerPac basic power supply are used for submerged...n agarose gels. This Model 192 cell includes a buf...h fluorescent ruler, and a gel caster. The PowerPa...des output of 10-300 V, 4-400 mA, and 75 W. Power ...
...ac 3000 system, 220-240 V, is used for nucleic aci...format. The system includes the modular Sequi-Gen ...ating nucleic acids with single base-pair resoluti...sembly (IPC and bonded inner glass plate, outer gl...
Biology Products: